Literature DB >> 27663384

In Vitro Release Mechanisms of Doxorubicin From a Clinical Bead Drug-Delivery System.

Emelie Ahnfelt1, Erik Sjögren1, Per Hansson1, Hans Lennernäs2.   

Abstract

The release rate of doxorubicin (DOX) from the drug-delivery system (DDS), DC Bead, was studied by 2 miniaturized in vitro methods: free-flowing and sample reservoir. The dependencies of the release mechanisms on in vitro system conditions were investigated experimentally and by theoretical modeling. An inverse relationship was found between release rates and bead size, most likely due to the greater total surface area. The release rates correlated positively with temperature, release medium volume, and buffer strength, although the release medium volume had larger effect than the buffer strength. The sample reservoir method generated slower release rates, which described the in vivo release profile more accurately than the free-flowing method. There was no difference between a pH of 6.3 or 7.4 on the release rate, implying that the slightly acidic tumor microenvironment is less importance for drug release. A positive correlation between stirring rate and release rate for all DDS sizes was observed, which suggests film controlled release. Theoretical modeling highlighted the influence of local equilibrium of protonation, self-aggregation, and bead material interactions of DOX. The theoretical release model might describe the observed larger sensitivity of the release rate to the volume of the release medium compared to buffer strength. A combination of miniaturized in vitro methods and theoretical modeling are useful to identify the important parameters and processes for DOX release from a micro gel-based DDS.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  controlled release; diffusion; dissolution; dissolution rate; drug-delivery systems; in vitro models; mathematical model; microspheres

Mesh:

Substances:

Year:  2016        PMID: 27663384     DOI: 10.1016/j.xphs.2016.08.011

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

Review 1.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

2.  Effect of Solvents, Stabilizers and the Concentration of Stabilizers on the Physical Properties of Poly(d,l-lactide-co-glycolide) Nanoparticles: Encapsulation, In Vitro Release of Indomethacin and Cytotoxicity against HepG2-Cell.

Authors:  Musaed Alkholief; Mohd Abul Kalam; Md Khalid Anwer; Aws Alshamsan
Journal:  Pharmaceutics       Date:  2022-04-15       Impact factor: 6.525

3.  Porcine and Human In Vivo Simulations for Doxorubicin-Containing Formulations Used in Locoregional Hepatocellular Carcinoma Treatment.

Authors:  Ilse R Dubbelboer; Erik Sjögren; Hans Lennernäs
Journal:  AAPS J       Date:  2018-08-30       Impact factor: 4.009

4.  Evaluation of immune-modulating drugs for use in drug-eluting microsphere transarterial embolization.

Authors:  Andrew S Mikhail; Michal Mauda-Havakuk; Ayele H Negussie; Natalie Hong; Natalie M Hawken; Camella J Carlson; Joshua W Owen; Olga Franco-Mahecha; Paul G Wakim; Andrew L Lewis; William F Pritchard; John W Karanian; Bradford J Wood
Journal:  Int J Pharm       Date:  2022-01-20       Impact factor: 6.510

5.  Description of Release Process of Doxorubicin from Modified Carbon Nanotubes.

Authors:  Dorota Chudoba; Monika Jażdżewska; Katarzyna Łudzik; Sebastian Wołoszczuk; Ewa Juszyńska-Gałązka; Mikołaj Kościński
Journal:  Int J Mol Sci       Date:  2021-11-05       Impact factor: 5.923

6.  A doxorubicin-platinum conjugate system: impacts on PI3K/AKT actuation and apoptosis in breast cancer cells.

Authors:  Puja Patel; Devan Umapathy; Selvambigai Manivannan; Vinita Manimaran Nadar; Rajiu Venkatesan; Velanganni Antony Joseph Arokiyam; Srinivasan Pappu; Kumar Ponnuchamy
Journal:  RSC Adv       Date:  2021-01-25       Impact factor: 3.361

7.  Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study.

Authors:  Elena Sánchez-López; Gerard Esteruelas; Alba Ortiz; Marta Espina; Josefina Prat; Montserrat Muñoz; Amanda Cano; Ana Cristina Calpena; Miren Ettcheto; Antoni Camins; Zaid Alsafi; Eliana B Souto; Maria Luisa García; Montserrat Pujol
Journal:  Nanomaterials (Basel)       Date:  2020-04-10       Impact factor: 5.076

8.  Preparation, Characterization and in vitro/in vivo Evaluation of Lovastatin-Loaded PLGA Microspheres by Local Administration for Femoral Head Necrosis.

Authors:  Yang Sun; Di Long
Journal:  Drug Des Devel Ther       Date:  2021-02-16       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.